MYX mayne pharma group limited

Ann: Notice under ASX Listing Rule 3.10A, page-5

  1. 1,523 Posts.
    lightbulb Created with Sketch. 269
    Examine the Reports !!
    Are you serious ?
    No you can’t be because had you
    studied the previous reports you
    may well find the many almost all
    never ending game changing promises
    in them that have never eventuated.
    Practice a little of what you preach . The
    generic approval of Nuvaring May be a
    good start . April 2018 is month when
    we were eligible to release to market.
    4 years ago in my reckoning. You are
    Scott in disguise. Go on admit it Stephen.
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)
Last
$5.00
Change
0.080(1.63%)
Mkt cap ! $406.2M
Open High Low Value Volume
$4.93 $5.10 $4.93 $3.062M 610.2K

Buyers (Bids)

No. Vol. Price($)
2 67102 $5.00
 

Sellers (Offers)

Price($) Vol. No.
$5.05 5000 1
View Market Depth
Last trade - 16.10pm 24/06/2025 (20 minute delay) ?
MYX (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.